AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine neoplasia type 1.

After listing its symptoms, it will discuss MEN1’s causes and risk factors. The article will then describe the diagnosis, treatment, and outlook of MEN1. MEN1 causes tumors to develop in some ...

“Reliable data on survival of MEN1 patients with liver metastases from [duodenopancreatic neuroendocrine tumors] are not available so far. Prognosis for advanced disease in MEN1 might be ...

If you have a parent with one of these diseases, you are slightly more likely to get some types of NETs: Multiple endocrine neoplasia type 1 (MEN1). It's a disease that causes tumors to form in ...

and genetic testing for MEN1 and HRPT2 mutations were undertaken. Diagnosis FIHP with primary hyperparathyroidism as the sole endocrinopathy due to a previously unreported heterozygous missense ...

The median age at breast cancer diagnosis for women with MEN1 (n = 22) was age 45 years vs. age 58 years in women without MEN1 (n = 14; P = .03) and age 61 years in the Dutch reference population ...

However, after a doctor has confirmed a diagnosis, surgical removal may resolve ... such as multiple endocrine neoplasia type 1 (MEN1). One article notes that MEN1 may contribute to the ...

1.33 to 2.88), and the average age at diagnosis was 51 years. Nuclear localization of menin was reduced by more than 50% in 8 of 10 breast-cancer samples obtained from Dutch patients with MEN1 on ...

A clinical NGS platform reveals pertubations of biologic pathways in metastatic panNETs that may inform prognosis and direct therapies ... In addition to frequent somatic mutations in MEN1 and TSC2, ...